What is the revised outlook for 2025 revenue and EPS, and how does it compare to analyst forecasts?
Answer
The press release you referenced only states that Ziff Davis, Inc. (NASDAQ: ZD) “reported unaudited financial results for the second quarter ended June 30 2025 and reaffirmed its 2025 guidance.” No new or “revised” figures for either 2025 revenue or 2025 earnings‑per‑share (EPS) were disclosed in the excerpt you provided. Consequently, the article does not give:
- a new revenue target (either an increase or decrease) for 2025;
- a new EPS target (either an increase or decrease) for 2025; nor
- any explicit comparison to Wall‑Street analyst consensus estimates.
What we can infer from the language used
| Phrase in the release | Typical implication in earnings releases |
|---|---|
| “reaffirmed its 2025 guidance” | The company is maintaining the previously‑issued 2025 outlook; it is not raising or lowering either the revenue or EPS targets. |
| “reported unaudited financial results” | The company has presented its Q2 numbers, but those results are not the basis for a new outlook; they are simply reported. |
Because the company reaffirmed rather than revised its guidance, the numbers that were originally set in earlier guidance remain the company’s official outlook for 2025. The press release does not repeat those numbers, so we cannot state them here.
How this compares to analyst forecasts
Since the news article does not contain:
- the actual 2025 revenue target,
- the actual 2025 EPS target,
- or any statement that the guidance has been changed (upward or downward),
we have no basis in this release to:
- State the company’s current 2025 revenue or EPS guidance; and
- Compare those numbers to analyst consensus estimates (which would be required for a direct “versus analyst forecast” comparison).
In other words, the article does not provide enough information to answer the question “What is the revised outlook for 2025 revenue and EPS, and how does it compare to analyst forecasts?” without pulling data from elsewhere (e.g., prior press releases, analyst consensus tables, or other filings).
What you would need to answer the question fully
To give a complete answer, the following data would be required:
| Required Data | Where it would normally appear |
|---|---|
| 2025 revenue guidance (e.g., “$2.3 billion ± 5%” or similar) | The “Guidance” section of the earnings release or the accompanying investor‑relations presentation. |
| 2025 EPS guidance (e.g., “$5.35 ± 5%”) | Same as above. |
| Analyst consensus forecasts (average, high‑low range, or median) | Analyst‑consensus tables from Bloomberg, FactSet, Refinitiv, or similar; often cited in the press release’s “Outlook” or “Analyst Expectations” section. |
| Any differences (e.g., company’s target is $100 M above or below the consensus) | This would be derived by comparing the two figures. |
If you have access to those numbers elsewhere (e.g., a prior press release, an earnings‑call transcript, or a consensus data table), you could simply insert them here and compare them directly (e.g., “Ziff Davis reaffirmed its 2025 revenue guidance of $2.3 billion, which is $150 million (≈7%) above the consensus estimate of $2.15 billion from analysts. Its EPS guidance of $5.35 per share is about $0.10 (≈2%) lower than the consensus EPS of $5.45 per share.”)
Bottom line
- The news snippet you provided does not contain a revised outlook for 2025 revenue or EPS.
- Therefore, we cannot compare the company's outlook to analyst forecasts based solely on the provided information.
If you need the exact numbers and the analyst‑consensus comparison, you will need to consult either:
- The full Ziff Davis Q2 2025 earnings release (which will include the current 2025 guidance figures), or
- An external consensus data source (e.g., Bloomberg, FactSet, Refinitiv) that lists analyst expectations for ZD’s 2025 revenue and EPS.
Once you have those numbers, you can easily compare the company’s reaffirmed guidance with the analyst estimates and highlight any upside or downside relative to market expectations.